Literature DB >> 32745970

Heart failure and diabetes: role of ATM.

Mary C Wingard1, Chad R Frasier1, Mahipal Singh1, Krishna Singh2.   

Abstract

Heart failure is a leading cause of death in the United States. Diabetes, also known as diabetes mellitus (DM), exponentially increases the risk of heart failure. The increase in oxidative stress and metabolic dysfunction caused by DM can lead to DNA damage and the development of diabetic cardiomyopathy. Ataxia telangiectasia mutated kinase (ATM) is a DNA damage response protein with a primary nuclear function to regulate cell cycle progression in response to double-strand DNA breaks, acts as a redox sensor, and facilitates DNA repair. ATM deficiency associates with the development of insulin resistance and DM. Consequently, patients with Ataxia telangiectasia, a rare autosomal recessive disorder, have an increased risk of developing heart failure. The main objective of this review is to summarize the shared metabolic and cardiac abnormalities associated with DM and ATM deficiency, with a focus on the development of heart failure. Published by Elsevier Ltd.

Entities:  

Year:  2020        PMID: 32745970      PMCID: PMC7769978          DOI: 10.1016/j.coph.2020.06.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  65 in total

Review 1.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

Review 2.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 3.  Ataxia-telangiectasia: A review of clinical features and molecular pathology.

Authors:  Parisa Amirifar; Mohammad Reza Ranjouri; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Pediatr Allergy Immunol       Date:  2019-03-20       Impact factor: 6.377

Review 4.  The ATM protein kinase and cellular redox signaling: beyond the DNA damage response.

Authors:  Scott Ditch; Tanya T Paull
Journal:  Trends Biochem Sci       Date:  2011-11-11       Impact factor: 13.807

5.  Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction.

Authors:  Laura L Daniel; Christopher R Daniels; Saghar Harirforoosh; Cerrone R Foster; Mahipal Singh; Krishna Singh
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

Review 6.  JNK at the crossroad of obesity, insulin resistance, and cell stress response.

Authors:  Giovanni Solinas; Barbara Becattini
Journal:  Mol Metab       Date:  2016-12-08       Impact factor: 7.422

Review 7.  The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.

Authors:  Zheng Xu; Jian Sun; Qian Tong; Qian Lin; Lingbo Qian; Yongsoo Park; Yang Zheng
Journal:  Int J Mol Sci       Date:  2016-12-08       Impact factor: 5.923

Review 8.  Present Insights on Cardiomyopathy in Diabetic Patients.

Authors:  João Soares Felício; Camila Cavalcante Koury; Carolina Tavares Carvalho; João Felício Abrahão Neto; Karem Barbosa Miléo; Thaís Pontes Arbage; Denisson Dias Silva; Alana Ferreira de Oliveira; Amanda Soares Peixoto; Antônio Bentes Figueiredo; Ândrea Kely Campos Ribeiro Dos Santos; Elizabeth Sumi Yamada; Maria Teresa Zanella
Journal:  Curr Diabetes Rev       Date:  2016

Review 9.  Cellular death, reactive oxygen species (ROS) and diabetic complications.

Authors:  Caroline Maria Oliveira Volpe; Pedro Henrique Villar-Delfino; Paula Martins Ferreira Dos Anjos; José Augusto Nogueira-Machado
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

10.  Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness.

Authors:  Janet B McGill; Mariko Johnson; Stacy Hurst; William T Cade; Kevin E Yarasheski; Richard E Ostlund; Kenneth B Schechtman; Babak Razani; Michael B Kastan; Donald A McClain; Lisa de Las Fuentes; Victor G Davila-Roman; Daniel S Ory; Samuel A Wickline; Clay F Semenkovich
Journal:  Diabetol Metab Syndr       Date:  2019-07-29       Impact factor: 3.320

View more
  4 in total

1.  [Exploring the therapeutic mechanism of quercetin for heart failure based on network pharmacology and molecular docking].

Authors:  X Tan; W Xian; Y Chen; X Li; Q Wang; P Kang; H Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-08-20

2.  Deficiency of ataxia-telangiectasia mutated kinase modulates functional and biochemical parameters of the heart in response to Western-type diet.

Authors:  Mary C Wingard; Suman Dalal; Paige L Shook; Rachel Myers; Barbara A Connelly; Douglas P Thewke; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 4.733

Review 3.  3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications.

Authors:  Earnest P Chen; Zeren Toksoy; Bruce A Davis; John P Geibel
Journal:  Front Bioeng Biotechnol       Date:  2021-05-13

4.  Deficiency of ataxia-telangiectasia mutated kinase attenuates Western-type diet-induced cardiac dysfunction in female mice.

Authors:  Mary C Wingard; Suman Dalal; Paige L Shook; Paulina Ramirez; Muhammad U Raza; Patrick Johnson; Barbara A Connelly; Douglas P Thewke; Mahipal Singh; Krishna Singh
Journal:  Physiol Rep       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.